Myocardial Infarction (MI)NCT07704827
Avatar-Based Serious Game for Cardiac Rehabilitation After Heart Attack
A study testing Avatar-based discharge education application and Standard discharge education in people with Myocardial Infarction (MI) and Cardiac Rehabilitation, run by Suleyman Demirel University at 1 site in Turkey (Türkiye).
Trial summary
This study looks at whether a tablet-based education game helps people recover better after a heart attack. When people leave the hospital after a heart attack, they are usually given advice about their medicines, follow-up visits, cardiac rehabilitation, and warning signs to watch for. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Myocardial Infarction (MI), Cardiac Rehabilitation
- What is being tested?
- Avatar-based discharge education application and Standard discharge education
- Type of treatment
- Pill or oral medicine, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 75 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 22 Sep 2025to 30 May 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Confirmed ST-elevation or non-ST-elevation myocardial infarction during the current admission or within the preceding three months, including patients readmitted for revascularization (percutaneous coronary intervention or coronary artery bypass grafting)
- Planned discharge to home
- Able to operate a tablet computer or a smart phone
- Provided written informed consent
Who cannot join
- Insufficient Turkish-language proficiency to engage with the application or study procedures
- Severe comorbidity precluding engagement in lifestyle behaviour change or exercise
- Significant cognitive or visual impairment
- Concurrent enrolment in another interventional study
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effectiveness of an Avatar-Based Serious Game in Facilitating Transition to Cardiac Rehabilitation After Myocardial Infarction: A Randomized Controlled Trial
This study looks at whether a tablet-based education game helps people recover better after a heart attack. When people leave the hospital after a heart attack, they are usually given advice about their medicines, follow-up visits, cardiac rehabilitation, and warning signs to watch for. Many people find it hard to remember all of this information later at home.
In this study, adults who were treated in hospital for a heart attack were divided by chance into two groups. One group received the usual face-to-face education before going home. The other group used an interactive avatar-based education game on a tablet, in which a guide character walks the patient through the same topics. The game could also be used at home for one month after discharge.
The researchers measured how much patients knew about their heart disease, their quality of life, whether they attended cardiac rehabilitation, and whether they were readmitted to hospital. These were checked before discharge and again at 1, 3, and 6 months. The goal is to learn whether the avatar-based game helps patients understand and manage their condition better than usual education.
- Conditions
- Myocardial Infarction (MI), Cardiac Rehabilitation
- Being tested
- Avatar-based discharge education application, Standard discharge education
- Medical subject headings
- Myocardial Infarction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Avatar-based discharge education applicationBehavioural
Tablet-based, avatar-guided discharge education application structured around Coleman's Care Transitions Intervention model (medication management, personal health record, follow-up continuity, and recognition of warning signs), delivered through interactive, persona-adapted, scenario-based gameplay before discharge and accessible for one month afterwards.
Standard discharge educationBehavioural
Standard face-to-face discharge education delivered individually by the principal investigator before discharge, covering medication management, personal health record keeping, follow-up continuity and cardiac rehabilitation, and recognition of warning signs.
| Study group | Role | What they receive |
|---|---|---|
| Control group | Active comparator | Not described Receives: Behavioral: Standard discharge education |
| Avatar-based education group | Experimental | Not described Receives: Behavioral: Avatar-based discharge education application |
What is being measured
The primary outcome is the main question the study is designed to answer.
Coronary artery disease knowledge (CADE-Q II)
Disease-related knowledge measured with the Coronary Artery Disease Education Questionnaire II (CADE-Q II), a 31-item instrument scored 0-93, with higher scores indicating greater knowledge.
Measured: Post-intervention and at 1, 3, and 6 months after discharge
Secondary outcomes (1)
Health-related quality of life (HeartQoL)
Disease-specific health-related quality of life measured with the HeartQoL questionnaire (14 items, total score 0-42), with higher scores indicating better quality of life.
Measured: Post-intervention and at 1, 3, and 6 months after discharge
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Jul 2026
- Study start22 Sep 2025
- Primary completion6 Jan 2026
- Study completion30 May 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Myocardial Infarction (MI)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 75 participants (actual)
Sponsor and investigators
- Lead sponsor
- Suleyman Demirel University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Afra ÇALIK, Suleyman Demirel University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07704827
- Sponsor's protocol ID
- E.1043124
- Status last verified
- Jul 2026
- First submitted
- 9 Jul 2026
- Last updated
- 16 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared publicly to protect participant privacy and in accordance with the approval conditions of the ethics committee and the informed consent obtained from participants. De-identified data may be made available from the corresponding author on reasonable request.
Publications
doi.org/10.1093/ehjdh/ztaf036
Study at a glance
From the registry record, last updated by the sponsor on 16 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of an Avatar-Based Serious Game in Facilitating Transition to Cardiac Rehabilitation After Myocardial Infarction: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07704827
- Acronym / sponsor ID
- E.1043124
- Conditions
- Myocardial Infarction (MI), Cardiac Rehabilitation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 75 participants (actual)
- Lead sponsor
- Suleyman Demirel UniversityUniversity, hospital or other
- Study start
- 22 Sep 2025 (actual)
- Primary completion
- 6 Jan 2026 (actual)
- Study completion
- 30 May 2026 (actual)
- First posted
- 15 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study looks at whether a tablet-based education game helps people recover better after a heart attack. When people leave the hospital after a heart attack, they are usually given advice about their medicines, follow-up visits, cardiac rehabilitation, and warning signs to watch for. Many people find it hard to remember all of this information later at home.
In this study, adults who were treated in hospital for a heart attack were divided by chance into two groups. One group received the usual face-to-face education before going home. The other group used an interactive avatar-based education game on a tablet, in which a guide character walks the patient through the same topics. The game could also be used at home for one month after discharge.
The researchers measured how much patients knew about their heart disease, their quality of life, whether they attended cardiac rehabilitation, and whether they were readmitted to hospital. These were checked before discharge and again at 1, 3, and 6 months. The goal is to learn whether the avatar-based game helps patients understand and manage their condition better than usual education.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Control group | Active comparator | Behavioral: Standard discharge education |
| Avatar-based education group | Experimental | Behavioral: Avatar-based discharge education application |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Confirmed ST-elevation or non-ST-elevation myocardial infarction during the current admission or within the preceding three months, including patients readmitted for revascularization (percutaneous coronary intervention or coronary artery bypass grafting)
- Planned discharge to home
- Able to operate a tablet computer or a smart phone
- Provided written informed consent
Key exclusion criteria (4 listed)
- Insufficient Turkish-language proficiency to engage with the application or study procedures
- Severe comorbidity precluding engagement in lifestyle behaviour change or exercise
- Significant cognitive or visual impairment
- Concurrent enrolment in another interventional study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Avatar-based discharge education applicationTablet-based, avatar-guided discharge education application structured around Coleman's Care Transitions Intervention model (medication management, personal health record, follow-up continuity, and recognition of warning signs), delivered through interactive, persona-adapted, scenario-based gameplay before discharge and accessible for one month afterwards. | Behavioural | Avatar-based education group |
| Standard discharge educationStandard face-to-face discharge education delivered individually by the principal investigator before discharge, covering medication management, personal health record keeping, follow-up continuity and cardiac rehabilitation, and recognition of warning signs. | Behavioural | Control group |
Primary outcome
Coronary artery disease knowledge (CADE-Q II)
Time frame: Post-intervention and at 1, 3, and 6 months after discharge
Disease-related knowledge measured with the Coronary Artery Disease Education Questionnaire II (CADE-Q II), a 31-item instrument scored 0-93, with higher scores indicating greater knowledge.
1 secondary outcome
Health-related quality of life (HeartQoL)
Time frame: Post-intervention and at 1, 3, and 6 months after discharge
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jul 2026.
- Backgrounddoi.org/10.1093/ehjdh/ztaf036
- Individual participant dataSharing planned: No. Individual participant data will not be shared publicly to protect participant privacy and in accordance with the approval conditions of the ethics committee and the informed consent obtained from participants. De-identified data may be made available from the corresponding author on reasonable request.
Related trials for Myocardial Infarction (MI)
RecruitingPhase 2
Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction
Myocardial Infarction, Reperfusion Injury
Recruiting
ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathY
Myocardial Infarction (MI), Sudden Cardiac Death Due to Cardiac Arrhythmia
RecruitingObservational study
Breisgau PHENO-HEART MI
Myocardial Infarction, STEMI
Not yet recruiting
Pilot Study to Determine the Optimal Protocol for Preoperative Transcutaneous Vagal Neurostimulation
Atrial Fibrillation (AF), Cerebral Vascular Accident (CVA)
Recruiting
Optimal Timing of Staged Complete Revascularization in STEMI With Multivessel Disease (OPTION-STEMI2)
Myocardial Infarction (MI)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Avatar-based discharge education application and Standard discharge education in people with Myocardial Infarction (MI) and Cardiac Rehabilitation, run by Suleyman Demirel University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Coronary artery disease knowledge (CADE-Q II) (time frame: Post-intervention and at 1, 3, and 6 months after discharge). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07704827, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2026.